Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (131-140 of 862) with videos related to

Pageof 87
Sort By:
Plos One|June 2, 2012
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptorsTamaki Ishima, Kenji Hashimoto
Annals of General Psychiatry|December 23, 2009
Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptorsTsutomu Furuse, Kenji Hashimoto
Human Psychopharmacology|April 8, 2010
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsideredIan Hindmarch, Kenji Hashimoto
The Primary Care Companion for CNS Disorders|April 16, 2013
Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 casesYakup Albayrak, Kenji Hashimoto
The Australian and New Zealand Journal of Psychiatry|October 5, 2014
Old drug tipepidine as new hope for children with ADHDKenji Hashimoto, Tsuyoshi Sasaki
Nihon Arukoru Yakubutsu Igakkai Zasshi = Japanese Journal of Alcohol Studies & Drug Dependence|June 4, 2008
[Progress in diagnosis of psychiatric diseases using blood samples--recent findings of brain-periphery interaction in drug abusers]Hiroko Hagiwara, Kenji Hashimoto
Annals of General Psychiatry|February 12, 2010
Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's diseaseTsutomu Furuse, Kenji Hashimoto
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2021
Reply to Reeves and Dunn: Risk for autism in offspring after maternal glyphosate exposureKenji Hashimoto, Bruce D Hammock
Journal of Clinical Psychopharmacology|September 2, 2011
Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trialYukihiko Shirayama, Takeshi Konishi, Kenji Hashimoto
Molecular Psychiatry|April 7, 2022
Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-MalekiYaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Pageof 87

Showing results (131-140 of 862) with videos related to

Sort By:
Pageof 87
Plos One|June 2, 2012
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptorsTamaki Ishima, Kenji Hashimoto
Annals of General Psychiatry|December 23, 2009
Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptorsTsutomu Furuse, Kenji Hashimoto
Human Psychopharmacology|April 8, 2010
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsideredIan Hindmarch, Kenji Hashimoto
The Primary Care Companion for CNS Disorders|April 16, 2013
Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 casesYakup Albayrak, Kenji Hashimoto
The Australian and New Zealand Journal of Psychiatry|October 5, 2014
Old drug tipepidine as new hope for children with ADHDKenji Hashimoto, Tsuyoshi Sasaki
Nihon Arukoru Yakubutsu Igakkai Zasshi = Japanese Journal of Alcohol Studies & Drug Dependence|June 4, 2008
[Progress in diagnosis of psychiatric diseases using blood samples--recent findings of brain-periphery interaction in drug abusers]Hiroko Hagiwara, Kenji Hashimoto
Annals of General Psychiatry|February 12, 2010
Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's diseaseTsutomu Furuse, Kenji Hashimoto
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2021
Reply to Reeves and Dunn: Risk for autism in offspring after maternal glyphosate exposureKenji Hashimoto, Bruce D Hammock
Journal of Clinical Psychopharmacology|September 2, 2011
Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trialYukihiko Shirayama, Takeshi Konishi, Kenji Hashimoto
Molecular Psychiatry|April 7, 2022
Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-MalekiYaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Pageof 87